Pawlak D, Chabielska E, Buczko W
Department of Pharmacodynamics, Medical Academy, Białystok, Poland.
Pol J Pharmacol. 1993 Jan-Feb;45(1):59-66.
Acetaldehyde (ACT), both, ex vivo and in vitro did not change the ADP-induced rat platelet aggregation and the potentiating action of serotonin. The whole blood serotonin content was decreased only when ACT was used in doses of 20 and 30 mg/kg, i.v. and the platelet serotonin content remained unchanged. Ex vivo, ACT had no influence on the labeled serotonin uptake, whereas in experiments in vitro it inhibited the amine uptake and augmented the serotonin release from blood platelets in a dose dependent manner. The results indicate that all the changes in the platelet serotonergic mechanisms appear only after high concentrations of ACT. They may be of significant importance in the circulatory system or hemostasis only during disulfiram or calcium carbamide therapy.
乙醛(ACT)在体内外均未改变二磷酸腺苷诱导的大鼠血小板聚集以及血清素的增强作用。仅当静脉注射20和30mg/kg剂量的ACT时,全血血清素含量才会降低,而血小板血清素含量保持不变。在体内,ACT对标记的血清素摄取没有影响,而在体外实验中,它以剂量依赖的方式抑制胺摄取并增加血小板血清素释放。结果表明,血小板血清素能机制的所有变化仅在高浓度的ACT后才出现。它们可能仅在双硫仑或脲基甲酸钙治疗期间对循环系统或止血具有重要意义。